Top

Tag: biotechnology


Biotech, Industry

Bora Pharmaceuticals Adds Roller Compaction Capabilities

April 9, 2021

Via: Contract Pharma

Bora Pharmaceutical Laboratories, a division of Bora Pharmaceuticals, has added roller compaction technology to its solid dose capability offerings at its Zhunan, Taiwan contract manufacturing and packaging facility. The Zhunan facility manufacturers complex oral solid dose (OSD) formulations with expertise […]


FDA, Regulations

FDA May be Getting Tougher, but Gives Trodelvy Nod for Triple-Negative Breast Cancer

April 9, 2021

Via: BioSpace

There has been discussion that the U.S. Food and Drug Administration (FDA) is getting tougher, and they are running an industry-wide evaluation of accelerated approvals. However, today the agency granted full approval to Gilead Sciences’ Trodelvy (Sacituzumab govitecan-hziy) for adults […]


News

FDA Grants Donisi De Novo Clearance for Innovative Contact-Free Multiparameter Health Sensing Solution

April 8, 2021

Via: BioSpace

The U.S. Food and Drug Administration (FDA) has granted Donisi’s revolutionary contact-free multiparameter measurement system de novo clearance, making Donisi the first to bring this innovative technology to the medical market. “I’m really proud of our team; we developed a […]


Manufacturing, News, Research and Development

Pharmaceutical Contract Development and Manufacturing Market | Exclusive Report on the Latest Trends and Market Revenues

April 8, 2021

Via: BioSpace

The rising popularity of outsourcing implementations across the healthcare industry due to the benefits such as affordability and less-time consumption will serve as a vital growth prospect for the pharmaceutical contract development and manufacturing market during the forecast period of […]


News

Rigel Announces Closing of Strategic Collaboration with Lilly

April 7, 2021

Via: BioSpace

Rigel Pharmaceuticals, Inc.. (Nasdaq: RIGL) today announced the successful closing of its license agreement with Eli Lilly and Company (Lilly), following the expiration of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976. Rigel and Lilly entered […]


Clinical Trials, News, Research and Development

Researchers Expose Hidden Atomic Portrait of Antioxidant Enzyme

April 7, 2021

Via: Genetic Engineering and Biotechnology News

Oxidative stress is caused by an imbalance between production and accumulation of oxygen reactive species (ROS) in cells and cells . Manganese superoxide dismutase (MnSOD) is an antioxidant enzyme that protects the mitochondria from oxidative damage by using a mechanism […]


Industry, News, Vaccines

Biden moves deadline for states to open Covid vaccines to all U.S. adults to April 19

April 6, 2021

Via: CNBC

President Joe Biden announced Tuesday that states should open Covid-19 vaccine appointments to all U.S. adults by April 19, moving up his original deadline by nearly two weeks. Biden announced the new deadline after he visited a vaccination site in […]


Biotech, Cell and Gene Therapy, Industry

HitGen and BioAge Announce Research Progress in DNA-Encoded Library Based Drug Discovery Research Collaboration

April 6, 2021

Via: BioSpace

Shanghai Stock Exchange listed biotech company HitGen Inc. (“HitGen”) announced important research progress in a collaboration with BioAge Labs, Inc. (“BioAge”), a private biotechnology company developing targeted small molecules for the treatment of diseases of aging. The companies have conducted […]


Biotech, FDA, Industry, Regulations

FDA Provides Positive Feedback on Tetra Bio-Pharma’s Application for ARDS-003 Clinical Development in COVID-19 Patients

April 5, 2021

Via: BioSpace

Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development is pleased to announce that the U.S. Food and Drug Administration (FDA) has favorably reviewed the preclinical data package and clinical development plan […]


Biotech, Industry, Manufacturing, News, Research and Development, Vaccines

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments

April 5, 2021

Via: BioSpace

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]


Industry, News, Vaccines

COVID-19 Vaccine Market: Nucleic acid vaccines segment to dominate global market

April 2, 2021

Via: BioSpace

COVID-19 is a pneumonic disease that is caused by SARS-Cov2 virus. Previous ancestors of COVID-19 virus are SARS-CoV and MERS Virus. Loss of few base pairs has led to the mutation in the genetic material of SARS-CoV2. High multiplication rate […]


Clinical Trials, News, Research and Development

Study identifies possible COVID-19 drugs — including several that are FDA-approved

April 2, 2021

Via: ScienceDaily

A team led by scientists in the Perelman School of Medicine at the University of Pennsylvania has identified nine potential new COVID-19 treatments, including three that are already approved by the Food and Drug Administration (FDA) for treating other diseases. […]